Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Lentigo in India
Total 0 results
Nothing found
Sponsors and Collaborators
Institute of Cancer Research (ICR), United Kingdom
Camille Levy
Clinical Oncology department. Elmansoura University.
Giovanni Mirabella
First People's Hospital of Shenyang
Colorado Childrens Hospital
Secretariat of Public Education (SEP)
Tarek Alsaied
Craving Change
Jorge Orduña-Valls
CellMaxLife
Innovative Therapies, Inc.
Azienda Unità Sanitaria Locale Reggio Emilia
Ozden Gokcek
Monroe Carell Jr. Children's Hospital at Vanderbilt
Holger Dressel
Ringerike sykehus, Vestre Viken HF
Amira Hussin Hussin Mohammed
Healthy Life
Facultad de Estudios Superiores Aragón UNAM
View Full List
Medical Conditions
Skin and Subcutaneous Tissue Infection
Drainage Procedure
CYP2C19 Poor
Body Height
MINI MENTAL STATE EXAMINATION TEST
Asthma, Allergic
Postoperative Analgesic Demand
Ascorbic Acid
Angiotensin-Converting Enzyme Inhibitors
Rectal Adenocarcinoma
Acute Myelogenous Leukemia (AML or ANLL)
Triple Negative Breast Cancer, TNBC
Human Herpes Virus-6 Infection
Peripheral Neuropathy Associated With Anti-myelin Associated Glycoprotein Antibodies (Anti-MAG Neuropathy)
Emergency Geriatric Care
Ventilator Induced Diaphragm Dysfunction
Post-operative Intercostal Neuralgia
Homologous Recombination Deficient Solid Tumors
Impulse-Control Disorders
Established Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD Risk
View Full List
Drug Interventions
GW-1000-02
Bevacizumab standard of care
Standard of care
Background regimen (BR) for MDR-TB (multi-drug resistant tuberculosis)
Prolonged release (PR) OROS methylphenidate 72 mg
Xenon
AZD7325
BMS-770767
Antithymocyte globulin (Rabbit)
Luliconazole Cream 1% - 2 wks
Leucovorin
Tenecteplase
Ascorbic Acid
RBS2418
Trastuzumab
AMT-101 (oral)
Fluvastatin
Topical Solution
Enfuvirtide-intensified HAART
Octreotide
View Full List
CROs by country
Contract Research Organizations in Australia
Contract Research Organizations in Bulgaria
Contract Research Organizations in Egypt
Contract Research Organizations in El Salvador
Contract Research Organizations in Ghana
Contract Research Organizations in Jordan
Contract Research Organizations in Lithuania
Contract Research Organizations in Luxembourg
Contract Research Organizations in Mexico
Contract Research Organizations in Montenegro
Contract Research Organizations in Switzerland
Contract Research Organizations in Uruguay
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in Uganda
MRC/UVRI Uganda Research Unit
SGS
Dokumeds
ACROSS Global
MCT
All CROs in Uganda
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe